Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag
Mandate

Vinge advises Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag

June 13, 2011

Vinge has advised Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag. Baggium AB has disposed of Baggium Vård & Behandling Aktiebolag which owns and operates 14 units to the Humana group. The operations have an approximate turnover of SEK 130 million with 125 employees and 140 students. Humana’s competence and experience in providing support for, and service to, children and young persons with special needs will provide the right conditions to develop the operations.
The Vinge team that advised Utbildning och Vård Koncern Sverige AB consisted of Petter Kjöllerström (project manager), Fabian Ekeblad (responsible partner), and associates Louise Markgren, Viveka Linander, Anders Frick, Linnéa Blommé, Julia Nordgren and project assistant Annika Johnson

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025